ABSTRACT: A method of introducing protease inhibitors into fish muscle through the bulbus arteriosus was developed using an in situ perfusion technique. Perfusion efficiency was initially tested using eosin and [
INTRODUCTION
Fish and shellfish are kept in cold storage after capture and are generally consumed within several days but the muscle freshness deteriorates even under cold storage. Because Japanese people like fresh slices of raw fish, consumers are interested in the freshness, and muscle texture is an especially important factor for freshness. The muscle structure is formed with myofibril and myostroma and is known to deteriorate during the 1st day of cold storage, affecting the muscle texture before rigor mortis occurs. [1] [2] [3] Histological observations have shown that decomposition of both the myofibrillar 4, 5 and myocomma [6] [7] [8] structures occur. Such a muscle-softening phenomenon in postmortem is thought to be caused by proteolysis of the muscle structure.
Several proteases have been studied as being causative factor for fish muscle softening such as cathepsins B, D, H and L, 9-14 calpain [15] [16] [17] and matrix metalloproteinase. 18 The material in most of these studies was drawn from particular meat that has an unusually soft texture and extremely high protease activity, such as jellied meat from Japanese flounder 14 and matured semelparity fish, [9] [10] [11] [12] [13] 18 which is known to have a soft muscle texture. In chum salmon 12 and ayu 13 muscle, high autolytic activities due to cathepsins have been shown to reduce the toughness of the meat in response to the sexual maturation process. In matured ayu muscle, matrix metalloproteinases (MMP) and matrix serine proteinases (MSP) have been identified and the induction of gelatinolytic activities has been demonstrated. 18 These anadromous and amphidromous fish die after spawning and death is thought to be programmed as apoptosis. If the soft muscle texture at the spawning stage is also programmed as part of apoptosis, there are some possibilities that caspase, a key protease of apoptosis, relates to post-mortem muscle softening. In the present study, because the aforementioned muscle proteases might be causative factors leading to post-mortem muscle softening of tilapia, four kinds of protease inhibitors were perfused into tilapia.
In contrast, there are few studies on the protease purification from ordinary fish muscle because of the low level of its activities. Recently, instead of protease purification, recombinant protein of MMP has been obtained using molecular technology to study post-mortem muscle softening. 19 Moreover, Kubota et al . used the direct method to demonstrate involvement of protease in the postmortem tenderization of fish muscle by injecting proteinase inhibitors into blood vessels in the caudal portion of live flounders. 20 This method seemed not to exclude the effect of blood fluid, in which factors inducing muscle softening may exist, because bleeding-treatment is believed to reduce the muscle softening when fish are killed for the raw fish trade. 21 In order to remove blood from fish muscle we developed an in situ perfusion technique, which introduced other chemicals into blood vessels in fish muscle. In the present study, using the in situ perfusion technique, four kinds of protease inhibitors were perfused to identify the type of proteases that led to post-mortem muscle softening.
MATERIALS AND METHODS

In situ perfusion
Tilapia Oreochromis niloticus were obtained from a private fish farm (Hamamatsu, Shizuoka, Japan) and reared at 20 ∞ C in the National Research Institute of Fisheries Science for several months before use. Fish were anesthetized with 200 p.p.m. MS222 (Tricaine methanesulfonate; Acros Organics, NJ, USA) and a cannula connected to a hypodermic syringe that was filled with physiological saline (0.7489% NaCl, 0.1294% KCl, 0.199% CaCl 2 ) was inserted into the bulbus arteriosus. A polyethylene tube (1.5 mm in diameter, 10 cm long) was inserted into the ventricle to bring the venous blood out of the fish body, so that it prevented the circulation of the venous blood and helped the physiological saline perfusion. Soon after the operation, the color of the fish gills changed to white from red and the color of the fluid from the polyethylene tube became clear approximately 10 min later. Finally after approximately 30 min, the liver color was observed to become whitish.
Eosin perfusion
Eosin (Wako Pure Chemical Industries, Osaka, Japan) was dissolved in physiological saline to obtain a 10% solution and this solution was perfused into tilapia (359-404 g, n = 2) using the in situ perfusion technique. After the perfusion of 40 mL of eosin solution ( ~ 40 min), the cannula was removed and the upper dorsal muscle was dissected. The muscle section was observed under a fluorescence stereoscopic microscope (R-400; Edge Scientific Instruments, CA, USA) using ultraviolet light to confirm the occurrence of fluorescence from the eosin. 
Protease inhibitor perfusion
Tilapia (867 ± 195 g) were obtained from a private fish farm (Kobayashi, Miyazaki, Japan) and reared in the Kobayashi Branch of Miyazaki Prefectural Fisheries Experimental Station using spring water. Each protease inhibitor (listed as follows): leupeptin (Peptide Institute, Osaka, Japan; 1 mg/mL), a serine and cysteine protease inhibitor; chymostatin (Peptide Institute; 1 mg/mL), a serine protease inhibitor; and benzyloxycarbonyl-Val-Ala-Aspfluoromethylketone (Z-VAD-fmk; Peptide Institute; 1 mg/mL), a caspase inhibitor; was dissolved in physiological saline. o -phenanthroline (Aldrich Chemical, WI, USA; 1 mM) a metalloprotease inhibitor, was dissolved in a small volume of methanol and diluted with physiological saline. These inhibitor solutions and physiological saline as the control sample ( n = 6) were perfused into tilapia for 60 min. A non-bled-fish sample ( n = 7) was obtained by leaving tilapia, which was not perfused, for 60 min on the experimental table after anesthesia. Each experimental group consisted of 10 tilapia ( n = 10). The cannula was removed and the upper dorsal muscle was sliced to give 1-cmwidth strips. The sample slices were wrapped in plastic film wrap individually and kept in a 4 ∞ C refrigerator until each measurement time (0, 4, 8,
12, 23, 50.5 and 73 h for control and non-bled-fish; 0, 23 and 50.5 h for inhibitor-perfused fish). The breaking strength of the slices as a parameter of muscle toughness was measured using a rheometer (NRM-20002 J, Hudoh, Tokyo, Japan) equipped with a cylindrical plunger of 3 mm diameter. The plunger was applied at the interspace between the myocomma membranes at the cut surface of the dorsal muscle. Measurements were taken at five points for each strip and the average value was calculated. Statistical differences were examined by analysis of variance at every measurement time.
RESULTS
In situ perfusion
Approximately 30 min after the perfusion of 10 mL physiological saline, the color of the fluid from the polyethylene tube became clear in the case of a 200-g tilapia. Previously the blood volume of tilapia has been shown to be approximately 4% of the body weight. 22 Thus, the same volume of perfusion solution as the blood volume was thought to be necessary for protease inhibitor perfusion.
Eosin perfusion
Eosin was used for visible confirmation of the in situ perfusion technique. Visible fluorescence was observed in the solution from the polyethylene tube, which confirmed the occurrence of eosin, approximately 3 min after the start of the eosin perfusion. This indicated that the circulation time of the blood through the body of tilapia after leaving the heart was approximately 3 min, which supported the calculated time of 2 min. 22 Eosin perfusion into the internal organs was confirmed under ultraviolet light after the upper lateral muscle was removed. Visible fluorescence was observed in the gill, liver, intestine and dorsal muscle in the eosin-treated tilapia (Fig. 1) . Blood vessel was seen as a black substance and/or black line in the longitudinal muscle section of eosinperfused tilapia under white light by stereoscopic microscope (Fig. 2a) . In the same section under ultraviolet light, eosin fluorescence was seen in the blood vessel, which was slightly brighter than the circumference area (Fig. 2b) . In contrast, any fluorescence in the blood vessels, which was confirmed under white light (Fig. 2c) , was not seen under ultraviolet light (Fig. 2d) . These results indicated that the marker substance, eosin, was perfused into each organ of the tilapia. 35 S]-methionine was used as a marker substance for a quantitative analysis of the perfusion efficiency. Radioactivity was taken into the dorsal muscle and liver at a concentration of 7.8 Bq/g and 70.2 Bq/g, respectively (Table 1 ). In tilapia, the liver received the radioactive substance approximately eightfold more than the dorsal muscle. The volume of extracellular fluid depended on the blood circulating volume and the liver has been shown to contain fivefold more space than white muscle in rainbow trout using [ 58 Co]-EDTA. 23 From these results of the eosin and [
35 S]-methionine perfusion experiments, this perfusion technique was concluded to be suitable for introducing chemical substances into fish muscle and was applied to protease inhibitor perfusion in the further experiments. Figure 3 shows the change in breaking strength of the muscles in the control sample ( n = 6) and nonbled-fish sample ( n = 7) at 0, 4, 8, 12, 23, 50.5 and 73 h during storage. The breaking strength of the non-bled-fish that was not treated by perfusion was 224 ± 57 gw at 0 h, reduced to 108 ± 13 gw at 23 h and then reached 86 ± 8 gw by 50.5 h. A similar tendency was observed in the control perfused with physiological saline in that the breaking strength was 198 ± 44 gw at 0 h, reduced to 100 ± Fig. 1 Fluorescence in the whole body of the eosin-perfused tilapia. The tilapia was anesthetized with MS222 and eosin was perfused by a cannula inserted into the bulbus arteriosus. Orange fluorescence of eosin was observed in the muscle, gill, liver and intestine under ultraviolet light.
Protease inhibitor perfusion
5 gw at 23 h and reached 82 ± 14 gw at 50.5 h. There was no difference between these two groups of fish by Student's t -test ( P = 0.9495). Because these data showed that the muscle toughness at 0 h was approximately 200 gw with a large variance, reduced rapidly within a day to approximately 100 gw with a low variance and remained almost constant until 73 h, we decided on measurement times of 0 h, 23 h and 50.5 h in the following experiments. Figure 4 shows the breaking strength of the muscle in each inhibitor group. Every tilapia was perfused with at least 30 mL perfusion solution. At the beginning of storage (0 h) the breaking strength of all the inhibitor-perfused fish was 144-197 gw with a large variance. The breaking strength with o -phenanthroline at 0 h was different from those with other inhibitors by analysis of variance and the o -phenanthroline-perfused experiments were not included in statistic analysis at 23 h (106 ± 20 gw) and 50.5 h. At 23 h storage, the breaking strength was reduced to 104-140 gw with a low variance and significant difference was found in the leupeptin (140 ± 36 gw, P = 0.0140)-and Z-VAD-fmk (139 ± 36 gw, P = 0.0162)-perfused fish, whereas no remarkable effect was seen in the chymostatin-perfused fish (104 ± 25 gw). At 50.5 h storage the breaking strength was 86-98 gw and statistic difference was not seen between the inhibitor-perfused fish. 
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DISCUSSION
The present study demonstrates that the in situ perfusion technique is suitable for the introduction of chemicals dissolved in physiological saline into tilapia. Moreover, leupeptin (serine and cysteine protease inhibitor) was effective to prevent the muscle softening but not chymostatin (serine protease inhibitor). In our unpublished experiment, E-64 (cysteine protease inhibitor) was found not to be effective to prevent muscle softening. Together with these findings, it is suggested that trypsin-like serine protease is the most probable candidate for protease involved in the postmortem softening in tilapia. Some trypsin-like serine proteases have been found in fish muscle [24] [25] [26] [27] [28] [29] [30] and these trypsin-like proteases might cleave muscle protein and cause muscle softening of tilapia during cold storage. However, these proteases have special characteristics that seem to make the purification easier, such as the unusual heat stability of the trypsin-like enzyme from cunner 24 and the myosin heavy chain-degrading activity of modori (kamaboko gel-degradation)-inducing proteases from threadfin bream. [26] [27] [28] [29] Because our unpublished study showed the activity of several types of serine proteases in the water-soluble and myofibrillar fractions of tilapia by assay using synthetic substrates, there is a possibility that other trypsin-like proteases might affect post-mortem softening in tilapia.
Z-VAD-fmk is an inhibitor of caspase, an apoptosis-causing enzyme. Apoptosis is a built-in termination mechanism of living cells and is induced by protein inducers and stress stimuli. Recently these mechanisms have been found to be induced by caspase-3 in fish. 31 The present finding that muscle softening was inhibited by caspase inhibitor suggests that caspase-3 activity is induced in fish muscle during cold storage after death. Apoptosis might occur in muscle cells during storage and induce the decomposition of the cytoskeletal proteins determining the meat toughness.
The effect of o-phenanthroline was not determined in the present study because the variance of o-phenanthroline at 0 h was different from other inhibitors. Because the present experiment was carried out following the same procedure throughout except for the person responsible for scooping up the fish with a net, the reason for this different variance is not known. However, Kubota et al. have shown the involvement of metalloprotease in the post-mortem softening in Japanese flounder, 19 and metalloprotease is very likely to be involved in tilapia as well.
Moreover, the present study found no difference between the breaking strength of non-bled-fish and controls, therefore the bleeding treatment was thought not to be effective for prevention of postmortem muscle softening in tilapia, which is a non-migratory fish. This result could be supported by Ando et al. 21 They found that bleeding effectively repressed muscle softening of migratory fish, but not non-migratory fish such as red sea bream, Japanese flounder and greenfish. In non-migratory fish the effective substances for causing postmortem softening might exist more in muscle components than in blood fluid.
The toughness of the raw meat was thought to be affected by the collagen content in myostroma, 32, 33 and the weakening of the pericellular connective tissue was suggested to cause the muscle softening. 34, 35 The degradation of Z-disk, however, has been observed in myofibrils, 4, 5 and limited digestion of a-actinin has been identified in red sea bream. 36 Recently the degradation of intermyofibrillar linkages and costameres, which are structures that link the myofibrils to the sarcolemmal cell membrane of muscle cells, was observed in bovine muscle. 37 Therefore in tilapia, leupeptin and caspase might prevent some of this degradation and affect post-mortem muscle softening. In order to understand the biochemical process involved in the post-mortem muscle softening more precisely, it is necessary to identify and characterize the muscle proteases in fish. 
